Medical Devices & Consumables
Global Drugs of Abuse Testing Market Research Report 2025
- May 12, 25
- ID: 243118
- Pages: 97
- Figures: 95
- Views: 1
The global market for Drugs of Abuse Testing was valued at US$ 756 million in the year 2024 and is projected to reach a revised size of US$ 1330 million by 2031, growing at a CAGR of 8.4% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drugs of Abuse Testing competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drugs of Abuse Testing Kits are used to test detect the presence of drugs such as marijuana, cocaine, opiates, methamphetamine, amphetamines, PCP, benzodiazepine, barbiturates, methadone, tricyclic antidepressants, ecstasy, and oxycodone etc in the urine, blood, saliva, hair, or sweat.
The global drug market is expanding year by year, and the problem of drug abuse is spreading. With the expansion of the world drug market and the continuous emergence of various new drugs, the cost of drug abuse is reduced and the number of drug users is increasing year by year. The demand for drug abuse detection kit market will only be increasing. The market development potential is still very huge. Owing to rise in cocaine production, Asia Pacific is also emerging as the hubs for cocaine trafficking and consumption. Owing to the increase of cocaine seizures, a paradigm shift toward an increase in users seeking treatment against drugs abuse has also been witnessed, which again has raised the importance of drug abuse testing kits globally.
In order to prevent deaths caused by overdose of drugs the governments of a number of countries have funded programs against drug abuse. The global governments spent large million in 2021 for screening, brief intervention and referral to treatment for drug usage. Also a number of countries have made it legal for workplaces to test their employees for drugs. The rise of supervision will undoubtedly drive the growth of the market.
Rising trend of POCT industry: The prevalence of various acute and chronic diseases has been rising in recent years. The large demand for rapid diagnosis and appropriate treatment has promoted the significant growth of POCT market. Drug abuse detection kit is a branch of POCT industry. The rapid and stable development of POCT industry has driven the development of drug abuse detection.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs of Abuse Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of Abuse Testing.
The Drugs of Abuse Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs of Abuse Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs of Abuse Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Thermo Fisher
Roche
Siemens Healthineers
Wondfo Biotech
Randox
OraSure
Draeger
InTec
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Segment by Type
Urine Testing
Saliva Testing
Blood Testing
Hair and Sweat Testing
Others
Segment by Application
Hospital
Law Enforcement
Drug Treatment Center
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs of Abuse Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs of Abuse Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drugs of Abuse Testing competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drugs of Abuse Testing Kits are used to test detect the presence of drugs such as marijuana, cocaine, opiates, methamphetamine, amphetamines, PCP, benzodiazepine, barbiturates, methadone, tricyclic antidepressants, ecstasy, and oxycodone etc in the urine, blood, saliva, hair, or sweat.
The global drug market is expanding year by year, and the problem of drug abuse is spreading. With the expansion of the world drug market and the continuous emergence of various new drugs, the cost of drug abuse is reduced and the number of drug users is increasing year by year. The demand for drug abuse detection kit market will only be increasing. The market development potential is still very huge. Owing to rise in cocaine production, Asia Pacific is also emerging as the hubs for cocaine trafficking and consumption. Owing to the increase of cocaine seizures, a paradigm shift toward an increase in users seeking treatment against drugs abuse has also been witnessed, which again has raised the importance of drug abuse testing kits globally.
In order to prevent deaths caused by overdose of drugs the governments of a number of countries have funded programs against drug abuse. The global governments spent large million in 2021 for screening, brief intervention and referral to treatment for drug usage. Also a number of countries have made it legal for workplaces to test their employees for drugs. The rise of supervision will undoubtedly drive the growth of the market.
Rising trend of POCT industry: The prevalence of various acute and chronic diseases has been rising in recent years. The large demand for rapid diagnosis and appropriate treatment has promoted the significant growth of POCT market. Drug abuse detection kit is a branch of POCT industry. The rapid and stable development of POCT industry has driven the development of drug abuse detection.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs of Abuse Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of Abuse Testing.
The Drugs of Abuse Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs of Abuse Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs of Abuse Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Thermo Fisher
Roche
Siemens Healthineers
Wondfo Biotech
Randox
OraSure
Draeger
InTec
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Segment by Type
Urine Testing
Saliva Testing
Blood Testing
Hair and Sweat Testing
Others
Segment by Application
Hospital
Law Enforcement
Drug Treatment Center
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs of Abuse Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs of Abuse Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Drugs of Abuse Testing Market Overview
1.1 Product Definition
1.2 Drugs of Abuse Testing by Type
1.2.1 Global Drugs of Abuse Testing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Urine Testing
1.2.3 Saliva Testing
1.2.4 Blood Testing
1.2.5 Hair and Sweat Testing
1.2.6 Others
1.3 Drugs of Abuse Testing by Application
1.3.1 Global Drugs of Abuse Testing Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Law Enforcement
1.3.4 Drug Treatment Center
1.3.5 Laboratory
1.3.6 Others
1.4 Global Drugs of Abuse Testing Market Size Estimates and Forecasts
1.4.1 Global Drugs of Abuse Testing Revenue 2020-2031
1.4.2 Global Drugs of Abuse Testing Sales 2020-2031
1.4.3 Global Drugs of Abuse Testing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drugs of Abuse Testing Market Competition by Manufacturers
2.1 Global Drugs of Abuse Testing Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drugs of Abuse Testing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drugs of Abuse Testing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drugs of Abuse Testing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
2.7 Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
2.8 Global Drugs of Abuse Testing Market Competitive Situation and Trends
2.8.1 Global Drugs of Abuse Testing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs of Abuse Testing Players Market Share by Revenue
2.8.3 Global Drugs of Abuse Testing Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs of Abuse Testing Market Scenario by Region
3.1 Global Drugs of Abuse Testing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drugs of Abuse Testing Sales by Region: 2020-2031
3.2.1 Global Drugs of Abuse Testing Sales by Region: 2020-2025
3.2.2 Global Drugs of Abuse Testing Sales by Region: 2026-2031
3.3 Global Drugs of Abuse Testing Revenue by Region: 2020-2031
3.3.1 Global Drugs of Abuse Testing Revenue by Region: 2020-2025
3.3.2 Global Drugs of Abuse Testing Revenue by Region: 2026-2031
3.4 North America Drugs of Abuse Testing Market Facts & Figures by Country
3.4.1 North America Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drugs of Abuse Testing Sales by Country (2020-2031)
3.4.3 North America Drugs of Abuse Testing Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs of Abuse Testing Market Facts & Figures by Country
3.5.1 Europe Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drugs of Abuse Testing Sales by Country (2020-2031)
3.5.3 Europe Drugs of Abuse Testing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs of Abuse Testing Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs of Abuse Testing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drugs of Abuse Testing Sales by Region (2020-2031)
3.6.3 Asia Pacific Drugs of Abuse Testing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs of Abuse Testing Market Facts & Figures by Country
3.7.1 Latin America Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drugs of Abuse Testing Sales by Country (2020-2031)
3.7.3 Latin America Drugs of Abuse Testing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs of Abuse Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drugs of Abuse Testing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drugs of Abuse Testing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs of Abuse Testing Sales by Type (2020-2031)
4.1.1 Global Drugs of Abuse Testing Sales by Type (2020-2025)
4.1.2 Global Drugs of Abuse Testing Sales by Type (2026-2031)
4.1.3 Global Drugs of Abuse Testing Sales Market Share by Type (2020-2031)
4.2 Global Drugs of Abuse Testing Revenue by Type (2020-2031)
4.2.1 Global Drugs of Abuse Testing Revenue by Type (2020-2025)
4.2.2 Global Drugs of Abuse Testing Revenue by Type (2026-2031)
4.2.3 Global Drugs of Abuse Testing Revenue Market Share by Type (2020-2031)
4.3 Global Drugs of Abuse Testing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drugs of Abuse Testing Sales by Application (2020-2031)
5.1.1 Global Drugs of Abuse Testing Sales by Application (2020-2025)
5.1.2 Global Drugs of Abuse Testing Sales by Application (2026-2031)
5.1.3 Global Drugs of Abuse Testing Sales Market Share by Application (2020-2031)
5.2 Global Drugs of Abuse Testing Revenue by Application (2020-2031)
5.2.1 Global Drugs of Abuse Testing Revenue by Application (2020-2025)
5.2.2 Global Drugs of Abuse Testing Revenue by Application (2026-2031)
5.2.3 Global Drugs of Abuse Testing Revenue Market Share by Application (2020-2031)
5.3 Global Drugs of Abuse Testing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Drugs of Abuse Testing Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Company Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Drugs of Abuse Testing Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Drugs of Abuse Testing Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Siemens Healthineers
6.4.1 Siemens Healthineers Company Information
6.4.2 Siemens Healthineers Description and Business Overview
6.4.3 Siemens Healthineers Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Siemens Healthineers Drugs of Abuse Testing Product Portfolio
6.4.5 Siemens Healthineers Recent Developments/Updates
6.5 Wondfo Biotech
6.5.1 Wondfo Biotech Company Information
6.5.2 Wondfo Biotech Description and Business Overview
6.5.3 Wondfo Biotech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wondfo Biotech Drugs of Abuse Testing Product Portfolio
6.5.5 Wondfo Biotech Recent Developments/Updates
6.6 Randox
6.6.1 Randox Company Information
6.6.2 Randox Description and Business Overview
6.6.3 Randox Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Randox Drugs of Abuse Testing Product Portfolio
6.6.5 Randox Recent Developments/Updates
6.7 OraSure
6.7.1 OraSure Company Information
6.7.2 OraSure Description and Business Overview
6.7.3 OraSure Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OraSure Drugs of Abuse Testing Product Portfolio
6.7.5 OraSure Recent Developments/Updates
6.8 Draeger
6.8.1 Draeger Company Information
6.8.2 Draeger Description and Business Overview
6.8.3 Draeger Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Draeger Drugs of Abuse Testing Product Portfolio
6.8.5 Draeger Recent Developments/Updates
6.9 InTec
6.9.1 InTec Company Information
6.9.2 InTec Description and Business Overview
6.9.3 InTec Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 InTec Drugs of Abuse Testing Product Portfolio
6.9.5 InTec Recent Developments/Updates
6.10 Orient Gene
6.10.1 Orient Gene Company Information
6.10.2 Orient Gene Description and Business Overview
6.10.3 Orient Gene Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Orient Gene Drugs of Abuse Testing Product Portfolio
6.10.5 Orient Gene Recent Developments/Updates
6.11 Hangzhou Biotest
6.11.1 Hangzhou Biotest Company Information
6.11.2 Hangzhou Biotest Description and Business Overview
6.11.3 Hangzhou Biotest Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hangzhou Biotest Drugs of Abuse Testing Product Portfolio
6.11.5 Hangzhou Biotest Recent Developments/Updates
6.12 Assure Tech
6.12.1 Assure Tech Company Information
6.12.2 Assure Tech Description and Business Overview
6.12.3 Assure Tech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Assure Tech Drugs of Abuse Testing Product Portfolio
6.12.5 Assure Tech Recent Developments/Updates
6.13 Aotai Bio
6.13.1 Aotai Bio Company Information
6.13.2 Aotai Bio Description and Business Overview
6.13.3 Aotai Bio Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aotai Bio Drugs of Abuse Testing Product Portfolio
6.13.5 Aotai Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs of Abuse Testing Industry Chain Analysis
7.2 Drugs of Abuse Testing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs of Abuse Testing Production Mode & Process Analysis
7.4 Drugs of Abuse Testing Sales and Marketing
7.4.1 Drugs of Abuse Testing Sales Channels
7.4.2 Drugs of Abuse Testing Distributors
7.5 Drugs of Abuse Testing Customer Analysis
8 Drugs of Abuse Testing Market Dynamics
8.1 Drugs of Abuse Testing Industry Trends
8.2 Drugs of Abuse Testing Market Drivers
8.3 Drugs of Abuse Testing Market Challenges
8.4 Drugs of Abuse Testing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Drugs of Abuse Testing by Type
1.2.1 Global Drugs of Abuse Testing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Urine Testing
1.2.3 Saliva Testing
1.2.4 Blood Testing
1.2.5 Hair and Sweat Testing
1.2.6 Others
1.3 Drugs of Abuse Testing by Application
1.3.1 Global Drugs of Abuse Testing Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Law Enforcement
1.3.4 Drug Treatment Center
1.3.5 Laboratory
1.3.6 Others
1.4 Global Drugs of Abuse Testing Market Size Estimates and Forecasts
1.4.1 Global Drugs of Abuse Testing Revenue 2020-2031
1.4.2 Global Drugs of Abuse Testing Sales 2020-2031
1.4.3 Global Drugs of Abuse Testing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drugs of Abuse Testing Market Competition by Manufacturers
2.1 Global Drugs of Abuse Testing Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drugs of Abuse Testing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drugs of Abuse Testing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drugs of Abuse Testing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
2.7 Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
2.8 Global Drugs of Abuse Testing Market Competitive Situation and Trends
2.8.1 Global Drugs of Abuse Testing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs of Abuse Testing Players Market Share by Revenue
2.8.3 Global Drugs of Abuse Testing Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs of Abuse Testing Market Scenario by Region
3.1 Global Drugs of Abuse Testing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drugs of Abuse Testing Sales by Region: 2020-2031
3.2.1 Global Drugs of Abuse Testing Sales by Region: 2020-2025
3.2.2 Global Drugs of Abuse Testing Sales by Region: 2026-2031
3.3 Global Drugs of Abuse Testing Revenue by Region: 2020-2031
3.3.1 Global Drugs of Abuse Testing Revenue by Region: 2020-2025
3.3.2 Global Drugs of Abuse Testing Revenue by Region: 2026-2031
3.4 North America Drugs of Abuse Testing Market Facts & Figures by Country
3.4.1 North America Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drugs of Abuse Testing Sales by Country (2020-2031)
3.4.3 North America Drugs of Abuse Testing Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs of Abuse Testing Market Facts & Figures by Country
3.5.1 Europe Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drugs of Abuse Testing Sales by Country (2020-2031)
3.5.3 Europe Drugs of Abuse Testing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs of Abuse Testing Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs of Abuse Testing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drugs of Abuse Testing Sales by Region (2020-2031)
3.6.3 Asia Pacific Drugs of Abuse Testing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs of Abuse Testing Market Facts & Figures by Country
3.7.1 Latin America Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drugs of Abuse Testing Sales by Country (2020-2031)
3.7.3 Latin America Drugs of Abuse Testing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs of Abuse Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs of Abuse Testing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drugs of Abuse Testing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drugs of Abuse Testing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs of Abuse Testing Sales by Type (2020-2031)
4.1.1 Global Drugs of Abuse Testing Sales by Type (2020-2025)
4.1.2 Global Drugs of Abuse Testing Sales by Type (2026-2031)
4.1.3 Global Drugs of Abuse Testing Sales Market Share by Type (2020-2031)
4.2 Global Drugs of Abuse Testing Revenue by Type (2020-2031)
4.2.1 Global Drugs of Abuse Testing Revenue by Type (2020-2025)
4.2.2 Global Drugs of Abuse Testing Revenue by Type (2026-2031)
4.2.3 Global Drugs of Abuse Testing Revenue Market Share by Type (2020-2031)
4.3 Global Drugs of Abuse Testing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drugs of Abuse Testing Sales by Application (2020-2031)
5.1.1 Global Drugs of Abuse Testing Sales by Application (2020-2025)
5.1.2 Global Drugs of Abuse Testing Sales by Application (2026-2031)
5.1.3 Global Drugs of Abuse Testing Sales Market Share by Application (2020-2031)
5.2 Global Drugs of Abuse Testing Revenue by Application (2020-2031)
5.2.1 Global Drugs of Abuse Testing Revenue by Application (2020-2025)
5.2.2 Global Drugs of Abuse Testing Revenue by Application (2026-2031)
5.2.3 Global Drugs of Abuse Testing Revenue Market Share by Application (2020-2031)
5.3 Global Drugs of Abuse Testing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Drugs of Abuse Testing Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Company Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Drugs of Abuse Testing Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Drugs of Abuse Testing Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Siemens Healthineers
6.4.1 Siemens Healthineers Company Information
6.4.2 Siemens Healthineers Description and Business Overview
6.4.3 Siemens Healthineers Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Siemens Healthineers Drugs of Abuse Testing Product Portfolio
6.4.5 Siemens Healthineers Recent Developments/Updates
6.5 Wondfo Biotech
6.5.1 Wondfo Biotech Company Information
6.5.2 Wondfo Biotech Description and Business Overview
6.5.3 Wondfo Biotech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wondfo Biotech Drugs of Abuse Testing Product Portfolio
6.5.5 Wondfo Biotech Recent Developments/Updates
6.6 Randox
6.6.1 Randox Company Information
6.6.2 Randox Description and Business Overview
6.6.3 Randox Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Randox Drugs of Abuse Testing Product Portfolio
6.6.5 Randox Recent Developments/Updates
6.7 OraSure
6.7.1 OraSure Company Information
6.7.2 OraSure Description and Business Overview
6.7.3 OraSure Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OraSure Drugs of Abuse Testing Product Portfolio
6.7.5 OraSure Recent Developments/Updates
6.8 Draeger
6.8.1 Draeger Company Information
6.8.2 Draeger Description and Business Overview
6.8.3 Draeger Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Draeger Drugs of Abuse Testing Product Portfolio
6.8.5 Draeger Recent Developments/Updates
6.9 InTec
6.9.1 InTec Company Information
6.9.2 InTec Description and Business Overview
6.9.3 InTec Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 InTec Drugs of Abuse Testing Product Portfolio
6.9.5 InTec Recent Developments/Updates
6.10 Orient Gene
6.10.1 Orient Gene Company Information
6.10.2 Orient Gene Description and Business Overview
6.10.3 Orient Gene Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Orient Gene Drugs of Abuse Testing Product Portfolio
6.10.5 Orient Gene Recent Developments/Updates
6.11 Hangzhou Biotest
6.11.1 Hangzhou Biotest Company Information
6.11.2 Hangzhou Biotest Description and Business Overview
6.11.3 Hangzhou Biotest Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hangzhou Biotest Drugs of Abuse Testing Product Portfolio
6.11.5 Hangzhou Biotest Recent Developments/Updates
6.12 Assure Tech
6.12.1 Assure Tech Company Information
6.12.2 Assure Tech Description and Business Overview
6.12.3 Assure Tech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Assure Tech Drugs of Abuse Testing Product Portfolio
6.12.5 Assure Tech Recent Developments/Updates
6.13 Aotai Bio
6.13.1 Aotai Bio Company Information
6.13.2 Aotai Bio Description and Business Overview
6.13.3 Aotai Bio Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aotai Bio Drugs of Abuse Testing Product Portfolio
6.13.5 Aotai Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs of Abuse Testing Industry Chain Analysis
7.2 Drugs of Abuse Testing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs of Abuse Testing Production Mode & Process Analysis
7.4 Drugs of Abuse Testing Sales and Marketing
7.4.1 Drugs of Abuse Testing Sales Channels
7.4.2 Drugs of Abuse Testing Distributors
7.5 Drugs of Abuse Testing Customer Analysis
8 Drugs of Abuse Testing Market Dynamics
8.1 Drugs of Abuse Testing Industry Trends
8.2 Drugs of Abuse Testing Market Drivers
8.3 Drugs of Abuse Testing Market Challenges
8.4 Drugs of Abuse Testing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drugs of Abuse Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drugs of Abuse Testing Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drugs of Abuse Testing Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drugs of Abuse Testing Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drugs of Abuse Testing Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drugs of Abuse Testing Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drugs of Abuse Testing Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drugs of Abuse Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drugs of Abuse Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
Table 12. Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs of Abuse Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Testing as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 18. Global Drugs of Abuse Testing Sales Market Share by Region (2020-2025)
Table 19. Global Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 20. Global Drugs of Abuse Testing Sales Market Share by Region (2026-2031)
Table 21. Global Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drugs of Abuse Testing Revenue Market Share by Region (2020-2025)
Table 23. Global Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drugs of Abuse Testing Revenue Market Share by Region (2026-2031)
Table 25. North America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 27. North America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 28. North America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drugs of Abuse Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drugs of Abuse Testing Sales (K Units) by Type (2020-2025)
Table 51. Global Drugs of Abuse Testing Sales (K Units) by Type (2026-2031)
Table 52. Global Drugs of Abuse Testing Sales Market Share by Type (2020-2025)
Table 53. Global Drugs of Abuse Testing Sales Market Share by Type (2026-2031)
Table 54. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drugs of Abuse Testing Revenue Market Share by Type (2020-2025)
Table 57. Global Drugs of Abuse Testing Revenue Market Share by Type (2026-2031)
Table 58. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drugs of Abuse Testing Sales (K Units) by Application (2020-2025)
Table 61. Global Drugs of Abuse Testing Sales (K Units) by Application (2026-2031)
Table 62. Global Drugs of Abuse Testing Sales Market Share by Application (2020-2025)
Table 63. Global Drugs of Abuse Testing Sales Market Share by Application (2026-2031)
Table 64. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drugs of Abuse Testing Revenue Market Share by Application (2020-2025)
Table 67. Global Drugs of Abuse Testing Revenue Market Share by Application (2026-2031)
Table 68. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Drugs of Abuse Testing Product
Table 74. Abbott Recent Developments/Updates
Table 75. Thermo Fisher Company Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Drugs of Abuse Testing Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche Drugs of Abuse Testing Product
Table 84. Roche Recent Developments/Updates
Table 85. Siemens Healthineers Company Information
Table 86. Siemens Healthineers Description and Business Overview
Table 87. Siemens Healthineers Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Siemens Healthineers Drugs of Abuse Testing Product
Table 89. Siemens Healthineers Recent Developments/Updates
Table 90. Wondfo Biotech Company Information
Table 91. Wondfo Biotech Description and Business Overview
Table 92. Wondfo Biotech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Wondfo Biotech Drugs of Abuse Testing Product
Table 94. Wondfo Biotech Recent Developments/Updates
Table 95. Randox Company Information
Table 96. Randox Description and Business Overview
Table 97. Randox Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Randox Drugs of Abuse Testing Product
Table 99. Randox Recent Developments/Updates
Table 100. OraSure Company Information
Table 101. OraSure Description and Business Overview
Table 102. OraSure Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OraSure Drugs of Abuse Testing Product
Table 104. OraSure Recent Developments/Updates
Table 105. Draeger Company Information
Table 106. Draeger Description and Business Overview
Table 107. Draeger Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Draeger Drugs of Abuse Testing Product
Table 109. Draeger Recent Developments/Updates
Table 110. InTec Company Information
Table 111. InTec Description and Business Overview
Table 112. InTec Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. InTec Drugs of Abuse Testing Product
Table 114. InTec Recent Developments/Updates
Table 115. Orient Gene Company Information
Table 116. Orient Gene Description and Business Overview
Table 117. Orient Gene Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Orient Gene Drugs of Abuse Testing Product
Table 119. Orient Gene Recent Developments/Updates
Table 120. Hangzhou Biotest Company Information
Table 121. Hangzhou Biotest Description and Business Overview
Table 122. Hangzhou Biotest Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hangzhou Biotest Drugs of Abuse Testing Product
Table 124. Hangzhou Biotest Recent Developments/Updates
Table 125. Assure Tech Company Information
Table 126. Assure Tech Description and Business Overview
Table 127. Assure Tech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Assure Tech Drugs of Abuse Testing Product
Table 129. Assure Tech Recent Developments/Updates
Table 130. Aotai Bio Company Information
Table 131. Aotai Bio Description and Business Overview
Table 132. Aotai Bio Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Aotai Bio Drugs of Abuse Testing Product
Table 134. Aotai Bio Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Drugs of Abuse Testing Distributors List
Table 138. Drugs of Abuse Testing Customers List
Table 139. Drugs of Abuse Testing Market Trends
Table 140. Drugs of Abuse Testing Market Drivers
Table 141. Drugs of Abuse Testing Market Challenges
Table 142. Drugs of Abuse Testing Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs of Abuse Testing
Figure 2. Global Drugs of Abuse Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs of Abuse Testing Market Share by Type: 2024 & 2031
Figure 4. Urine Testing Product Picture
Figure 5. Saliva Testing Product Picture
Figure 6. Blood Testing Product Picture
Figure 7. Hair and Sweat Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Drugs of Abuse Testing Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Drugs of Abuse Testing Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Law Enforcement
Figure 13. Drug Treatment Center
Figure 14. Laboratory
Figure 15. Others
Figure 16. Global Drugs of Abuse Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drugs of Abuse Testing Market Size (2020-2031) & (US$ Million)
Figure 18. Global Drugs of Abuse Testing Sales (2020-2031) & (K Units)
Figure 19. Global Drugs of Abuse Testing Average Price (US$/Unit) & (2020-2031)
Figure 20. Drugs of Abuse Testing Report Years Considered
Figure 21. Drugs of Abuse Testing Sales Share by Manufacturers in 2024
Figure 22. Global Drugs of Abuse Testing Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Drugs of Abuse Testing Players: Market Share by Revenue in Drugs of Abuse Testing in 2024
Figure 24. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 27. North America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 31. Europe Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 32. Germany Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Drugs of Abuse Testing Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Drugs of Abuse Testing Revenue Market Share by Region (2020-2031)
Figure 39. China Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 50. Latin America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 60. Global Revenue Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 61. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 63. Global Revenue Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 64. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2031)
Figure 65. Drugs of Abuse Testing Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Drugs of Abuse Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drugs of Abuse Testing Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drugs of Abuse Testing Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drugs of Abuse Testing Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drugs of Abuse Testing Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drugs of Abuse Testing Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drugs of Abuse Testing Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drugs of Abuse Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drugs of Abuse Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
Table 12. Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs of Abuse Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Testing as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 18. Global Drugs of Abuse Testing Sales Market Share by Region (2020-2025)
Table 19. Global Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 20. Global Drugs of Abuse Testing Sales Market Share by Region (2026-2031)
Table 21. Global Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drugs of Abuse Testing Revenue Market Share by Region (2020-2025)
Table 23. Global Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drugs of Abuse Testing Revenue Market Share by Region (2026-2031)
Table 25. North America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 27. North America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 28. North America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drugs of Abuse Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drugs of Abuse Testing Sales (K Units) by Type (2020-2025)
Table 51. Global Drugs of Abuse Testing Sales (K Units) by Type (2026-2031)
Table 52. Global Drugs of Abuse Testing Sales Market Share by Type (2020-2025)
Table 53. Global Drugs of Abuse Testing Sales Market Share by Type (2026-2031)
Table 54. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drugs of Abuse Testing Revenue Market Share by Type (2020-2025)
Table 57. Global Drugs of Abuse Testing Revenue Market Share by Type (2026-2031)
Table 58. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drugs of Abuse Testing Sales (K Units) by Application (2020-2025)
Table 61. Global Drugs of Abuse Testing Sales (K Units) by Application (2026-2031)
Table 62. Global Drugs of Abuse Testing Sales Market Share by Application (2020-2025)
Table 63. Global Drugs of Abuse Testing Sales Market Share by Application (2026-2031)
Table 64. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drugs of Abuse Testing Revenue Market Share by Application (2020-2025)
Table 67. Global Drugs of Abuse Testing Revenue Market Share by Application (2026-2031)
Table 68. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Drugs of Abuse Testing Product
Table 74. Abbott Recent Developments/Updates
Table 75. Thermo Fisher Company Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Drugs of Abuse Testing Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche Drugs of Abuse Testing Product
Table 84. Roche Recent Developments/Updates
Table 85. Siemens Healthineers Company Information
Table 86. Siemens Healthineers Description and Business Overview
Table 87. Siemens Healthineers Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Siemens Healthineers Drugs of Abuse Testing Product
Table 89. Siemens Healthineers Recent Developments/Updates
Table 90. Wondfo Biotech Company Information
Table 91. Wondfo Biotech Description and Business Overview
Table 92. Wondfo Biotech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Wondfo Biotech Drugs of Abuse Testing Product
Table 94. Wondfo Biotech Recent Developments/Updates
Table 95. Randox Company Information
Table 96. Randox Description and Business Overview
Table 97. Randox Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Randox Drugs of Abuse Testing Product
Table 99. Randox Recent Developments/Updates
Table 100. OraSure Company Information
Table 101. OraSure Description and Business Overview
Table 102. OraSure Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OraSure Drugs of Abuse Testing Product
Table 104. OraSure Recent Developments/Updates
Table 105. Draeger Company Information
Table 106. Draeger Description and Business Overview
Table 107. Draeger Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Draeger Drugs of Abuse Testing Product
Table 109. Draeger Recent Developments/Updates
Table 110. InTec Company Information
Table 111. InTec Description and Business Overview
Table 112. InTec Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. InTec Drugs of Abuse Testing Product
Table 114. InTec Recent Developments/Updates
Table 115. Orient Gene Company Information
Table 116. Orient Gene Description and Business Overview
Table 117. Orient Gene Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Orient Gene Drugs of Abuse Testing Product
Table 119. Orient Gene Recent Developments/Updates
Table 120. Hangzhou Biotest Company Information
Table 121. Hangzhou Biotest Description and Business Overview
Table 122. Hangzhou Biotest Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hangzhou Biotest Drugs of Abuse Testing Product
Table 124. Hangzhou Biotest Recent Developments/Updates
Table 125. Assure Tech Company Information
Table 126. Assure Tech Description and Business Overview
Table 127. Assure Tech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Assure Tech Drugs of Abuse Testing Product
Table 129. Assure Tech Recent Developments/Updates
Table 130. Aotai Bio Company Information
Table 131. Aotai Bio Description and Business Overview
Table 132. Aotai Bio Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Aotai Bio Drugs of Abuse Testing Product
Table 134. Aotai Bio Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Drugs of Abuse Testing Distributors List
Table 138. Drugs of Abuse Testing Customers List
Table 139. Drugs of Abuse Testing Market Trends
Table 140. Drugs of Abuse Testing Market Drivers
Table 141. Drugs of Abuse Testing Market Challenges
Table 142. Drugs of Abuse Testing Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs of Abuse Testing
Figure 2. Global Drugs of Abuse Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs of Abuse Testing Market Share by Type: 2024 & 2031
Figure 4. Urine Testing Product Picture
Figure 5. Saliva Testing Product Picture
Figure 6. Blood Testing Product Picture
Figure 7. Hair and Sweat Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Drugs of Abuse Testing Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Drugs of Abuse Testing Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Law Enforcement
Figure 13. Drug Treatment Center
Figure 14. Laboratory
Figure 15. Others
Figure 16. Global Drugs of Abuse Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drugs of Abuse Testing Market Size (2020-2031) & (US$ Million)
Figure 18. Global Drugs of Abuse Testing Sales (2020-2031) & (K Units)
Figure 19. Global Drugs of Abuse Testing Average Price (US$/Unit) & (2020-2031)
Figure 20. Drugs of Abuse Testing Report Years Considered
Figure 21. Drugs of Abuse Testing Sales Share by Manufacturers in 2024
Figure 22. Global Drugs of Abuse Testing Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Drugs of Abuse Testing Players: Market Share by Revenue in Drugs of Abuse Testing in 2024
Figure 24. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 27. North America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 31. Europe Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 32. Germany Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Drugs of Abuse Testing Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Drugs of Abuse Testing Revenue Market Share by Region (2020-2031)
Figure 39. China Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 50. Latin America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 60. Global Revenue Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 61. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 63. Global Revenue Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 64. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2031)
Figure 65. Drugs of Abuse Testing Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232